All tagged covid-19

California: Skilled nursing facilities account for 34% of state's Covid deaths

STAFF REPORTS

Zero Californians below age 17 have died due to Covid 19. Seventy-five percent of all of the state’s Covid deaths involve patients over 65 years old. And 46% of those deaths occurred in skilled nursing facilities. Statewide, resident Covid deaths from these facilities account for 34 percent of all California deaths as of August 9, 2020, according to the California Department of Public Health..

A skilled nursing facility is an inpatient center for rehabilitation and therapy, as opposed to a senior center which provides 24/7 residential care for those who can no longer care for themselves.

Michigan hospital study shows hydroxychloroquine cut death rates by half

A retrospective, peer-reviewed study by the Henry Ford Health System in Detroit found that hospitalized Covid-19 patients who received the anti-malaria drug hydroxychloroquine early in their stay were half as likely to die as the control group, the nonprofit hospital announced Thursday. The study’s author, Dr. Marcus Zervos, attributed the results to the timing of patients receiving HCQ.

The Ford press release stated:

“In a large-scale retrospective analysis of 2,541 patients hospitalized between March 10 and May 2, 2020, across the system’s six hospitals, the study found 13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine. None of the patients had documented serious heart abnormalities; however, patients were monitored for a heart condition routinely pointed to as a reason to avoid the drug as a treatment for COVID-19.”

Here are the main clinical trials of hydroxychloroquine for first responders

The clinical term for these studies is PrEP, which stands for Pre-Exposure Prophylaxis. All of the following studies involve PrEP. The studies with the soonest expected date of completion are the Ford Health System (June 30, 2020) and Duke University (July 2020).

Duke University : HERO HCQ Study

  • Patient-Centered Outcomes Research Institute committing $50 million

  • double-blind, placebo-controlled, randomized trial with treatment course of 30 days.

  • 15,000 patients at 17 locations in 12 states

  • Principal investigator: Adrian Hernandez, M.D., cardiologist and executive director of Duke Clinical Research Institute

  • Estimated primary completion date: July 2020

Texas Pharmacy Board reverses rule on hydroxychloroquine, no longer restricting 'off-label' use

By TATIANA PROPHET

A rule adopted March 20 by the Texas State Board of Pharmacy restricting the prescribing of anti-malaria and lupus drug hydroxychloroquine has been reversed, after a Dallas physician gained national attention for her difficulty in prescribing the drug for her Covid-19 patients.

“I have patients that recovered within 48 hours,” Dr. Lozano told fellow protesters May 9 at the “Set Texas Free” event in Dallas. She went on to describe how CVS pharmacy was refusing to fill her prescriptions.

The rule, which applied to chloroquine, hydroxychloroquine and azithromycin, prohibited the dispensing of the medication without a written diagnosis “consistent with the evidence for its use.” Further, it limited prescriptions to a 14-day supply and required “no refills,” according to the taxpayer watchdog site Texas Scorecard.

Zinc/Z-pack and HCQ show promise in NYU study

An NYU study that involved 100 mg of zinc sulfate added to hydroxychloroquine, shows that people given that combo, with azithromycin, are 45 percent less likely to die from Covid-19, 46 percent less likely to be transferred to intensive care, and 38 percent likely to be put on a ventilator. But once a patient is transferred to intensive care, the odds of survival go way down even with the HCQ cocktail.

Read all about it.

Spectrum's 24-hour New York City cable channel, NY-1, has been one of the few outlets following hydroxychloroquine (two articles so far on the Langone trials). And more studies will be coming out of NYU — including double-blind and randomized, as well as the University of South Dakota, and Cedars-Sinai in Los Angeles.